Fundz

Citius Oncology secures up to $36.5 million in debt and equity capital led by Avenue Capital, advancing LYMPHIR® commercialization efforts.

PUBLIC · CTORMay 06, 2026

Amount Raised

$36.5 Million

Round Type

Venture

United StatesBiotechnologyHealth CareMedicalTherapeuticsPharmaceuticalBiopharma

Investors

Avenue Capital GroupAvenue Venture Opportunities Fund II, L.P.

Description

Citius Oncology, Inc. has entered a senior secured term loan credit facility with Avenue Capital Group for up to $25 million. An additional $11.5 million is expected from the exercise of outstanding warrants. These funds support the ongoing commercialization of LYMPHIR®, enhancing financial flexibility

Company Information

Company

Citius Oncology

Location

United States

About

Citius Oncology, Inc. is a Delaware-based clinical-stage biopharmaceutical company focused on developing innovative therapies for the treatment of cancer. The company specializes in the development of novel cancer treatments, including targeted therapies and immunotherapies, designed to improve the effectiveness and safety of cancer care. Citius Oncology operates primarily in the United States and is listed on The Nasdaq Capital Market under the ticker symbol CTOR. The company's strategic focus includes advancing its pipeline of therapies through clinical trials, positioning itself to address unmet medical needs in oncology, and catering to the growing demand for effective cancer treatments.

Fundz sees it the moment Citius Oncology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsLeonard M., Chief Executive Officer hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Citius Oncology's next move

See what Strategic adds

Citius Oncology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.